Search

Your search keyword '"Nisticò, Cecilia"' showing total 6 results
Start Over Author "Nisticò, Cecilia" Publication Year Range Last 3 years
6 results on '"Nisticò, Cecilia"'

1. Impact of comorbidity on outcome and treatment choice in patients with head and neck squamous cell carcinoma (HNSCC).

Author

Giacinti, Silvana, primary, Giannarelli, Diana, additional, Moi, Rossana, additional, Battista, Michele, additional, Perfetti, Alessandra, additional, Ferrari, Laura, additional, Alò, Piero Luigi, additional, Costanzo, Filippo, additional, Marzetti, Andrea, additional, Cognetti, Francesco, additional, and Nisticò, Cecilia, additional

Published
2024
Full Text
View/download PDF

2. Dose-dense adjuvant chemotherapy in patients with HER2-low early breast cancer: An exploratory analysis of the GIM2 trial.

Author

Molinelli, Chiara, primary, Delucchi, Virginia, additional, Blondeaux, Eva, additional, Boni, Luca, additional, Poggio, Francesca, additional, Arpino, Grazia, additional, Nisticò, Cecilia, additional, Fabi, Alessandra, additional, De Laurentiis, Michelino, additional, Puglisi, Fabio, additional, Nader Marta, Guilherme, additional, Fozza, Alessandra, additional, Pitto, Francesca, additional, Lambertini, Matteo, additional, and Del Mastro, Lucia, additional

Published
2024
Full Text
View/download PDF

3. Supplementary Figure S1 from HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care

Author

Fabi, Alessandra, primary, Di Benedetto, Anna, primary, Metro, Giulio, primary, Perracchio, Letizia, primary, Nisticò, Cecilia, primary, Di Filippo, Franco, primary, Ercolani, Cristiana, primary, Ferretti, Gianluigi, primary, Melucci, Elisa, primary, Buglioni, Simonetta, primary, Sperduti, Isabella, primary, Papaldo, Paola, primary, Cognetti, Francesco, primary, and Mottolese, Marcella, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Table S1 from HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care

Author

Fabi, Alessandra, primary, Di Benedetto, Anna, primary, Metro, Giulio, primary, Perracchio, Letizia, primary, Nisticò, Cecilia, primary, Di Filippo, Franco, primary, Ercolani, Cristiana, primary, Ferretti, Gianluigi, primary, Melucci, Elisa, primary, Buglioni, Simonetta, primary, Sperduti, Isabella, primary, Papaldo, Paola, primary, Cognetti, Francesco, primary, and Mottolese, Marcella, primary

Published
2023
Full Text
View/download PDF

5. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

Author

Del Mastro, Lucia, primary, Poggio, Francesca, additional, Blondeaux, Eva, additional, De Placido, Sabino, additional, Giuliano, Mario, additional, Forestieri, Valeria, additional, De Laurentiis, Michelino, additional, Gravina, Adriano, additional, Bisagni, Giancarlo, additional, Rimanti, Anita, additional, Turletti, Anna, additional, Nisticò, Cecilia, additional, Vaccaro, Angela, additional, Cognetti, Francesco, additional, Fabi, Alessandra, additional, Gasparro, Simona, additional, Garrone, Ornella, additional, Alicicco, Maria Grazia, additional, Urracci, Ylenia, additional, Mansutti, Mauro, additional, Poletti, Paola, additional, Correale, Pierpaolo, additional, Bighin, Claudia, additional, Puglisi, Fabio, additional, Montemurro, Filippo, additional, Colantuoni, Giuseppe, additional, Lambertini, Matteo, additional, Boni, Luca, additional, Venturini, M, additional, Abate, A, additional, Pastorino, S, additional, Canavese, G, additional, Vecchio, C, additional, Guenzi, M, additional, Lambertini, M, additional, Levaggi, A, additional, Giraudi, S, additional, Accortanzo, V, additional, Floris, C.A., additional, Aitini, E, additional, Fornari, G, additional, Miraglia, S, additional, Buonfanti, G, additional, Cherchi, M.C., additional, Petrelli, F, additional, Vaccaro, A, additional, Magnolfi, E, additional, Contu, A, additional, Labianca, R, additional, Parisi, A, additional, Basurto, C, additional, Cappuzzo, F, additional, Merlano, M, additional, Russo, S, additional, Mansutti, M, additional, Poletto, E, additional, Nardi, M, additional, Grasso, D, additional, Fontana, A, additional, Isa, L, additional, Comandè, M, additional, Cavanna, L, additional, Iacobelli, S, additional, Milani, S, additional, Mustacchi, G, additional, Venturini, S, additional, Scinto, A.F., additional, Sarobba, M.G., additional, Pugliese, P, additional, Bernardo, A, additional, Pavese, I, additional, Coccaro, M, additional, Massidda, B, additional, Ionta, M.T., additional, Nuzzo, A, additional, Laudadio, L, additional, Chiantera, V, additional, Dottori, R, additional, Barduagni, M, additional, Castiglione, F, additional, Ciardiello, F, additional, Tinessa, V, additional, Ficorella, A, additional, Moscetti, L, additional, Vallini, I, additional, Giardina, G, additional, Silva, R, additional, Montedoro, M, additional, Seles, E, additional, Morano, F, additional, Cruciani, G, additional, Adamo, V, additional, Pancotti, A, additional, Palmisani, V, additional, Ruggeri, A, additional, Cammilluzzi, E, additional, Carrozza, F, additional, D'Aprile, M, additional, Brunetti, M, additional, Gallotti, P, additional, Chiesa, E, additional, Testore, F, additional, D'Arco, A, additional, Ferro, A, additional, Jirillo, A, additional, Pezzoli, M, additional, Scambia, G, additional, Iacono, C, additional, Masullo, P, additional, Tomasello, G, additional, Gandini, G, additional, Zoboli, A, additional, Bottero, C, additional, Cazzaniga, M, additional, Genua, G, additional, Palazzo, S, additional, D'Amico, M, additional, and Perrone, D, additional

Published
2022
Full Text
View/download PDF

6. Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases.

Author

Cicini, Maria Paola, Ferretti, Gianluigi, Morace, Nicola, Nisticò, Cecilia, Cognetti, Francesco, and Rulli, Francesco

Subjects
CARDIOTOXICITY, ECHOCARDIOGRAPHY, PROTEIN kinase inhibitors, HEART block, CARDIAC pacing, DUCTAL carcinoma, BREAST cancer, CARDIAC pacemakers, HORMONE receptor positive breast cancer
Abstract

Introduction: A wide spectrum of cardiovascular (CV) toxicity is associated with anticancer treatment, and nearly all chemotherapeutic agents can elicit CV toxicity. Inhibitors of cyclin-dependent kinases 4/6 (CDK4/6Is) have become standard of care in the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer (MBC). CV side effects are uncommon with CDK4/6Is and only include QT prolongation, with a low incidence rate. Case Presentation: This paper describes 2 cases of new-onset second-degree type 2 atrioventricular (AV) blocks requiring permanent cardiac pacing involving 2 women with MBC receiving ribociclib or abemaciclib. Both our patients had no known history or risk factors of cardiac disease and a normal 12-lead resting electrocardiogram (ECG) when diagnosed with breast adenocarcinoma. Both patients have been subjected to surveillance for cardiotoxicity with serial ECG and echocardiography. No left ventricular dysfunction or arrhythmia was found during the follow-up, and cardiac biomarkers were normal. Conclusion: To our knowledge, these are the first cases reported in the literature of new-onset advanced AV blocks in patients under treatment with CDK4/6Is, suggesting the clinical relevance of a more frequent ECG monitoring, besides the QT interval, in these patients. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results